CEO Executive AssistantDelegation for insurance enterprise risk management sits at the intersection of regulatory obligation, capital discipline, and strategic decision-making. Unlike many other functions you can delegate with relatively broad parameters, risk management in insurance is subject to regulator scrutiny, board oversight requirements, and capital framework rules that shape exactly how governance must be structured. If your Chief Risk Officer is operating without a clear mandate, if risk appetite thresholds live in a document no one references, or if stress test results are reviewed after strategic decisions rather than informing them, your ERM framework is a compliance exercise rather than a management tool.
This article gives you a practical structure for delegating enterprise risk management oversight to your CRO and risk committee, including how to set a risk appetite that functions as a decision-making constraint, how to govern stress testing, and how to keep yourself appropriately informed without duplicating the work your risk function should be doing.
Why Delegation for Insurance Enterprise Risk Management Is Different
Risk management delegation in insurance is not simply about assigning work to a qualified executive. It involves three parallel accountability structures that you must understand and design simultaneously.
Regulatory accountability. Insurance regulators in most jurisdictions require the board and CEO to demonstrate active oversight of enterprise risk. Own Risk and Solvency Assessment (ORSA) requirements in the United States, Solvency II in Europe, and equivalent frameworks globally require CEO attestation of the risk management process. You cannot fully delegate regulatory accountability. But you can delegate the operational substance of risk management while retaining the oversight posture regulators require.
Board accountability. The board (typically through an audit and risk committee or a dedicated risk committee) expects to receive risk management information in a form that allows them to exercise genuine oversight. The CRO’s role includes producing that information. Your role includes ensuring the CRO presents it in a way that enables the board to act rather than simply to be informed.
Operational accountability. Risk management must be embedded in business decisions, not bolted on after the fact. The CRO needs operational authority to identify, measure, and report risks arising from underwriting, investment, claims, distribution, and technology functions, even when those functions report to other executives.
These three accountability structures require three different kinds of delegation design. This article addresses all three.
Structuring the CRO’s Mandate
The CRO’s mandate should be documented in a formal Risk Management Charter, reviewed and approved by the board risk committee annually. The charter should specify the following.
Independence. The CRO reports directly to the CEO for operational purposes and has a dotted-line reporting relationship to the board risk committee. This dual reporting ensures the CRO has organizational standing to raise concerns that business leaders might prefer to minimize, without bypassing the CEO.
Risk identification authority. The CRO has authority to identify and formally register any risk that poses a material threat to the company’s financial position, regulatory standing, or strategic objectives, across all functions and business units. Functional leaders cannot prevent the CRO from registering a risk or reporting it to the management team.
Risk assessment authority. The CRO has authority to assess the severity and likelihood of registered risks using approved methodologies, and to assign risk ratings without approval from the functional leaders whose activities generate the risk. This independence is essential to the credibility of the risk function.
Risk reporting authority. The CRO reports risk status to the executive team monthly and to the board risk committee quarterly, without the requirement for CEO approval of the content of those reports. This does not mean the CEO is excluded from reviewing the reports before presentation. It means the CRO cannot be instructed to omit or soften material risk information.
Risk limit monitoring. The CRO owns the process of monitoring adherence to risk limits defined in the risk appetite statement, and is the designated party to trigger escalation when a limit is approached or breached.
What the CRO does not own: the decision to accept, transfer, or mitigate individual risks. Those decisions belong to the business leaders who manage the activities generating the risk, in consultation with the CRO and subject to risk appetite limits you have set.
Setting the Risk Appetite: The CEO’s Core Contribution
The risk appetite statement is the most important output of your engagement with the enterprise risk management framework. Everything else in the ERM structure, risk limits, stress test thresholds, escalation triggers, is a downstream implementation of the risk appetite you establish.
Your role is not to write the risk appetite statement. The CRO drafts it, working with the CFO, Chief Actuary, and relevant business leaders. Your role is to make the decisions that determine the statement’s content, and to own the statement as a strategic document that reflects your view of how much risk is appropriate for the company to carry in pursuit of its objectives.
A well-designed insurance risk appetite statement covers the following dimensions.
Capital adequacy. Define the minimum capital ratio (for example, an RBC ratio floor or an economic capital buffer) below which the company will not operate without a board-approved remediation plan. This is your most important risk boundary. Everything else is constrained by it.
Earnings volatility. Define an acceptable range of annual earnings volatility. For example: the company is willing to accept a one-in-ten-year scenario in which underwriting earnings decline by up to 20 percent, but a scenario with a greater than 30 percent earnings decline in any year would require strategic response.
Underwriting risk concentration. Define maximum acceptable accumulations of risk by geography, peril, line of business, or single insured. These limits constrain the CUO’s portfolio composition decisions and are monitored by the CRO.
Liquidity risk. Define a minimum liquidity coverage ratio or claims-paying coverage metric that cannot be breached under base-case assumptions. Stress scenarios may breach this threshold, but the business plan should not.
Reputational and conduct risk. Articulate qualitative boundaries around the types of risks the company will not take, even if they are financially attractive, because of their reputational or conduct implications. This is harder to quantify but signals important cultural boundaries.
Once the risk appetite statement is approved by the board, it functions as a delegated authority document in reverse: it tells every executive in the organization the boundaries within which they can make decisions without CEO escalation, and the thresholds that require escalation when approached.
Governing Stress Tests: What to Delegate and What to Retain
Stress testing is the mechanism by which the risk appetite is translated into operational insight. The CRO owns the stress test program: scenario design, model execution, result compilation, and reporting. Your role is to define the strategic scenarios you want tested and to ensure stress test results are used to inform decisions, not filed as compliance outputs.
McKinsey research on enterprise risk management effectiveness distinguishes between risk functions that generate insight and those that generate reports. The differentiating factor is almost always whether senior leadership uses stress test outputs to make decisions.
Here is how to ensure that happens.
Define the annual stress test agenda. At the start of each year, work with the CRO to identify the three to five scenarios most relevant to your strategic and capital planning cycle. These should include at least one catastrophe scenario relevant to your underwriting portfolio, one macroeconomic scenario (recession, rate shock, or inflation surge), one regulatory scenario (significant RBC change or new reporting requirement), and one emerging risk scenario chosen based on your strategic horizon.
Integrate stress test results into the planning cycle. The CRO presents stress test results in advance of the annual strategic planning and capital allocation cycle, not after it. The CFO and Chief Actuary use stress test outputs to validate financial projections and capital adequacy assumptions. This makes stress testing a strategic input, not a retrospective audit.
Review exception scenarios personally. You do not need to review the full stress test program. You do need to review any scenario in which results show the company’s capital ratio falling below the risk appetite floor, or earnings volatility exceeding the defined tolerance. These are the scenarios that inform whether your strategy is financially durable under adverse conditions.
Delegate the rest. Routine scenario modeling, sensitivity analysis, model validation, and regulatory stress test submissions belong entirely to the CRO and Chief Actuary. You receive a summary of results and exception flags. You do not review the underlying models.
Risk Committee Governance
The management risk committee, chaired by the CRO and attended by the CFO, Chief Actuary, CUO, CIO, and COO, is the primary operational governance forum for enterprise risk management. This committee meets monthly, reviews the risk register, monitors limit adherence, discusses emerging risks, and produces minutes that are reviewed by the CEO and presented in summary to the board risk committee.
You should not chair this committee. When the CEO chairs the risk committee, two problems emerge. First, the CRO becomes a meeting facilitator rather than a risk leader, which undermines their ability to raise independent concerns. Second, business leaders who report to the CEO are less likely to disclose risks openly when the CEO is in the room.
A stronger design: you attend the management risk committee quarterly, not monthly. For the other nine meetings each year, the CRO chairs and you receive the minutes within five business days. You send a written response to the minutes flagging any items requiring follow-up or decision. This keeps you informed without your presence shaping the committee’s dynamic.
For board-level risk governance, the CRO presents directly to the board risk committee, with you providing context on strategic implications. Reinforce to the board that the CRO’s report represents the independent risk function’s view. Your role at the board is to demonstrate strategic engagement with risk, not to validate or moderate the CRO’s findings.
Connect ERM governance explicitly to your investment oversight framework, as the two functions share common capital management dependencies. See investment delegation for this integration.
Emerging Risk Identification: A Specific Delegation Gap
Many insurance companies delegate current-state risk management effectively but underinvest in emerging risk identification. The risk register covers known risks in current portfolios. Emerging risks (climate transition risk, cyber accumulation, AI-driven fraud, or new regulatory categories) may not appear in current portfolios but can become material within your strategic planning horizon.
Assign the CRO explicit responsibility for an annual Emerging Risk Horizon Scan. This is a structured exercise, typically conducted in the first quarter, that reviews risks outside the current risk register and assesses their potential materiality within a three to five year horizon. The output is a one-page Emerging Risk Summary presented to the executive team and the board risk committee.
The Emerging Risk Horizon Scan should draw on external sources: regulatory consultation papers, reinsurer emerging risk reports, industry association research, and cross-sector intelligence from peer networks. The CRO coordinates this research; they do not produce it entirely in-house.
When the Horizon Scan identifies an emerging risk that could affect your strategic plan, it triggers a joint discussion between the CRO, CFO, and the relevant business leader about whether the strategic plan needs adjustment or whether a monitoring protocol should be established. You make the final call on strategic plan adjustments. The CRO makes the call on monitoring protocols.
What to Report to the Board
Your board risk committee needs three things from the ERM function: assurance that risk management is operating effectively, visibility into material risk concentrations, and confirmation that the company’s risk profile is consistent with the approved risk appetite.
Structure board risk reporting around the following.
Quarterly Risk Dashboard: A one-page traffic-light view of each risk appetite dimension, showing current status versus defined limits. The CRO presents this in 20 minutes, with a brief narrative on any amber or red items and the management response.
Annual ORSA Summary: A board-level review of the ORSA process, key stress test results, capital adequacy conclusions, and any changes proposed to the risk appetite statement. This takes 60 minutes and should occur before the board approves the annual financial plan.
Ad hoc notifications: When a risk limit is breached or a material emerging risk requires board awareness, the CRO notifies the board risk committee chair directly, with a copy to the CEO, within 24 hours of identification. The board chair decides whether to convene a special session or address the matter at the next scheduled meeting.
You can also link the board risk reporting cadence to your CX governance reporting by flagging conduct and reputational risk items that arise from customer experience failures. See CX delegation to integrate these reporting streams.
Common Mistakes That Undermine ERM Delegation
Treating ORSA as a compliance document. When the ORSA is filed with the regulator without meaningful CEO engagement, it provides regulatory cover but no strategic value. Make it a genuine strategic exercise by reviewing scenarios personally and testing your plan against the results.
Allowing functional leaders to override risk assessments. When a business leader escalates a risk rating to the CEO and you change it informally, the risk function’s independence is compromised. Correct factual errors through the risk committee process, not through informal override.
Under-resourcing the CRO function. A framework covering investment, underwriting, operational, cyber, and regulatory risk requires real quantitative capability. Delegating ERM without adequate CRO resources is a governance failure, not a cost management success.
Confusing risk oversight with risk avoidance. The purpose of ERM is not to minimize risk. It is to ensure risks are understood, within appetite, and appropriately priced. A CRO without a framework for calibrating acceptable risk-taking is not serving the company’s strategic needs.
Conclusion
Delegation for insurance enterprise risk management is the governance structure that allows you to lead a risk-taking enterprise with confidence. When the CRO has a clear mandate, the risk appetite is explicit and operational, stress tests inform decisions rather than satisfy regulators, and reporting flows without requiring your constant involvement, you have built an ERM framework that works.
Your role is not to manage risk directly. Your role is to set the risk appetite that defines the boundaries of acceptable risk-taking, to ensure the CRO has the authority and resources to operate the framework effectively, and to engage substantively at the strategic inflection points where risk assessment should shape your decisions.
That is the purpose of delegation for insurance enterprise risk management: not to remove yourself from the accountability, but to ensure the accountability is discharged by a function with the expertise, independence, and mandate to do it well.